Product Description
For adaptive servo-ventilation, indicated and approved for clinical use in Switzerland, European Union, and other countries (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820538/)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: N/A
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Insel Gruppe AG, University Hospital Bern
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
eSATIS | N/A |
Unknown status |
Sleep Apnea, Central|Stroke|Sleep Apnea, Obstructive |
2022-03-05 |